Chemical Structure (Nabumetone 01)
Nabumetone Tablet
Product Images NDC 69367-241
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 69367-241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Nabumetone 02)
Figure (Nabumetone 03)
This is a chart that shows the plasma concentrations of the nabumetone active metabolite (BMNA) at steady state, following once-daily dosing of either 1000 mg or 2000 mg of nabumetone. There were 31 participants in the 1000 mg group and 12 participants in the 2000 mg group. The chart shows the concentration levels over time, ranging from 0 to 24 hours.*
Principal Display Panel (500 mg Tablet Bottle Label)
Each tablet contains 500mg of Nabumetone, which is a USP medication. The usual dosage is not available, but prescribing information is available with the item. The tablets should be stored at a temperature ranging from 20°C to 25°C (68°F to 77°F). Excursions from this temperature range are permitted up to 15°C to 30°C (59°F to 86°F). The product should be dispensed in a tightly sealed and light-resistant container. The medication guide must be provided to each patient. The product is manufactured by ScieGen Pharmaceuticals Inc. and distributed by Westminster Pharmaceuticals LLC. This product is available in a bottle containing 500 tablets.*
Principal Display Panel (750 mg Tablet Bottle Label)
Each tablet of this medication contains 750 mg of Nabumetone, USP. It is recommended to store it at 20° to 25°C (68°F to 77°%), excursions permitted 1 15°C 0 30°C (59°F to 86°F) in a tight, light-resistant container with a child-resistant closure. This medication should be kept out of reach of children. It comes with an accompanying medication guide to be dispensed to each patient. Manufactured by ScieGen Pharmaceuticals, Inc. for Westminster Pharmaceuticals, LLC. This bottle contains 500 tablets.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
